Earnings Call · Q1 FY2021·2021-05-09

Q1 21EPS +28.16%·Rev n/aQ4 20EPS -48.39%·Rev n/aQ3 20EPS -2.86%·Rev n/aQ2 20EPS -13.33%·Rev n/a⚠ consensus missing

Natera, Inc. NTRA

Michael Brophy — Chief Financial Officer

Steve Chapman — Chief Executive Officer

Solomon Moshkevich — General Manager of Oncology

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more NTRA calls or request research access.

More NTRA calls Browse calls Request research access